Gene · 10021
Papers1,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Twelve-Lead ECG, Holter Monitoring Parameters, and Genetic Testing in Brugada Syndrome: Insights from Analysis of Multigenerational Family with a History of Sudden Cardiac Arrest during Physical Activity. | J Clin Med | 2023 | 37892719 | PubTator, text mining | PubMed |
| Pre-natal clues of a genetic tale: how foetal heart rate foretells long QT syndrome. | Europace | 2023 | 37882612 | PubTator, text mining | PubMed |
| Structures of a sperm-specific solute carrier gated by voltage and cAMP. | Nature | 2023 | 37880361 | PubTator, text mining | PubMed |
| Direct regulation of the voltage sensor of HCN channels by membrane lipid compartmentalization. | Nat Commun | 2023 | 37852983 | PubTator, text mining | PubMed |
| Noncoding RNAs and Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Cardiac Arrhythmic Brugada Syndrome. | Cells | 2023 | 37830612 | PubTator, text mining | PubMed |
| ERRγ agonist under mechanical stretching manifests hypertrophic cardiomyopathy phenotypes of engineered cardiac tissue through maturation. | Stem Cell Reports | 2023 | 37802074 | PubTator, text mining | PubMed |
| Outcomes of hypothalamic oxytocin neuron-driven cardioprotection after acute myocardial infarction. | Basic Res Cardiol | 2023 | 37801130 | PubTator, text mining | PubMed |
| New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models. | Sci Rep | 2023 | 37775650 | PubTator, text mining | PubMed |
| Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment. | Front Bioeng Biotechnol | 2023 | 37771571 | PubTator, text mining | PubMed |
| Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes. | Int J Mol Sci | 2023 | 37762236 | PubTator, text mining | PubMed |
| Non-Coding RNAs and Gut Microbiota in the Pathogenesis of Cardiac Arrhythmias: The Latest Update. | Genes (Basel) | 2023 | 37761875 | PubTator, text mining | PubMed |
| The Action Potential Clamp Technique as a Tool for Risk Stratification of Sinus Bradycardia Due to Loss-of-Function Mutations in HCN4: An In Silico Exploration Based on In Vitro and In Vivo Data. | Biomedicines | 2023 | 37760888 | PubTator, text mining | PubMed |
| Beauvericin Immunotoxicity Prevention by Gentiana lutea L. Flower In Vitro. | Toxins (Basel) | 2023 | 37755964 | PubTator, text mining | PubMed |
| Genetic mechanisms underlying arrhythmogenic mitral valve prolapse: Current and future perspectives. | Heart Rhythm O2 | 2023 | 37744942 | PubTator, text mining | PubMed |
| Cardiac microRNAs: diagnostic and therapeutic potential. | Arch Med Sci | 2023 | 37732050 | PubTator, text mining | PubMed |
| The neurophysiological basis of stress and anxiety - comparing neuronal diversity in the bed nucleus of the stria terminalis (BNST) across species. | Front Cell Neurosci | 2023 | 37711509 | PubTator, text mining | PubMed |
| A pilot study evaluating the role of ivabradine for rate control in patients with rheumatic atrial fibrillation. | Indian Heart J | 2023 | 37666416 | PubTator, text mining | PubMed |
| Clinical and Genetic Features of Korean Inherited Arrhythmia Probands. | Korean Circ J | 2023 | 37653714 | PubTator, text mining | PubMed |
| Structural Basis for Hyperpolarization-dependent Opening of the Human HCN1 Channel. | bioRxiv | 2023 | 37645882 | PubTator, text mining | PubMed |
| DNA methylation cooperates with H3K9me2 at HCN4 promoter to regulate the differentiation of bone marrow mesenchymal stem cells into pacemaker-like cells. | PLoS One | 2023 | 37643180 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10021/papers?page=7